United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 5, 2026 · Filed Aug 6, 2026

On Aug 5, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$518.73 for US$4.93M under a trading plan, leaving 324,443 shares. Filed Aug 6, 2026 (Form 4).

Sold
9,500 shares
Price
US$518.73 average (US$502.29 to US$524.59)
Value
US$4.93M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 5, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 5, 2026Common StockSale200US$502.29333,743Indirect
Aug 5, 2026Common StockSale80US$504.31333,663Indirect
Aug 5, 2026Common StockSale160US$507.24333,503Indirect
Aug 5, 2026Common StockSale160US$510.28333,343Indirect
Aug 5, 2026Common StockSale80US$511.07333,263Indirect
Aug 5, 2026Common StockSale529US$514.28332,734Indirect
Aug 5, 2026Common StockSale205US$515.44332,529Indirect
Aug 5, 2026Common StockSale386US$516.72332,143Indirect
Aug 5, 2026Common StockSale557US$517.48331,586Indirect
Aug 5, 2026Common StockSale1,891US$518.51329,695Indirect
Aug 5, 2026Common StockSale1,496US$519.62328,199Indirect
Aug 5, 2026Common StockSale1,011US$520.58327,188Indirect
Aug 5, 2026Common StockSale1,385US$521.64325,803Indirect
Aug 5, 2026Common StockSale939US$522.66324,864Indirect
Aug 5, 2026Common StockSale261US$523.88324,603Indirect
Aug 5, 2026Common StockSale160US$524.59324,443Indirect

Source

View original at SEC

Related